does tirzepatide increase energy did not impact metabolic adaptation in people with obesity, but increased fat oxidation Tirzepatide for Medical Weight Loss

Nonfatal myocardial infarction occurred in 2.3% of patients treated with oral semaglutide and 1.9% treated with placebo (HR 1.18, 95% CI 0.731.90), nonfatal stroke occurred in 0.8% versus 1.0% treated with placebo (HR 0.74, 95% CI 0.351.57), and death from cardiovascular causes occurred in 0.9% versus 1.9% treated with placebo (HR 0.51, 95% CI 0.310.84)

However, the benefits and side effects will vary with each individual due to dosage, age, and other health considerations

Planta 239, 12651279

Focus on sufficient protein intake, incorporate resistance training two to three times per week, maintain hydration, and prioritize sleep